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ABSTRACT
Psychoactive substance disorders among prison inmates are challenges to the prison 
authority, and this may interfere with the processes of reformation and rehabilitation 
therein. The study assessed the prevalence, pattern, and correlates of psychoactive 
substance use in a cross-sectional study involving 552 new inmates in a custodial center 
in Enugu, Nigeria. Diagnoses were made using the MINI-Plus (version 6) in line with 
the ICD 10. Lifetime and 12-month prevalence of psychoactive substance disorder were 
57.4% and 50.7%, respectively. The commonest substance disorders were tobacco 
(48.2% lifetime and 41.1% 12-month), cannabis (36.8% lifetime, and 32.4% 12-month), 
and alcohol (7.2% lifetime, and 6.9% 12-month).
Descriptive statistics, Mann-Whitney U test, Chi-squared test, and regression analyses 
were performed to assess the extent to which socio-demographic characteristics, type of 
offence, and family dysfunction predicted psychoactive substance use or disorder. Four 
hundred and seventy eight (86.6%) of participants had used psychoactive substance in 
their lifetime, while it was 405 (73.4%) in the last 12 months prior to imprisonment. 
Lifetime and 12-month rates of psychoactive substance disorder were 57.4% (n=317) 
and 50.7% (n=280), respectively. Male gender, unemployment, parental divorce, and 
parental drug use respectively, significantly predicted 12-month psychoactive substance 
disorder [β = 0.12, 95% (CI: 0.04, 0.39)], [β = 1.79, 95% (CI: 1.24, 2.60)], [β = 0.29, 95% 
(CI: 0.14, 0.59)], and [β = 0.56, 95% (CI: 0.39, 0.81)]. Lifetime disorder was significantly 
predicted by male gender [β = 0.12, 95% (CI: 0.04, 0.35)], unemployment [β = 1.60, 95% 
(CI: 1.10, 2.32)], parental divorce [β = 0.23, 95% (CI: 0.10, 0.52)], and parental drug use 
[β = 0.49, 95% (CI: 0.34, 0.72)]. Similarly, lifetime psychoactive substance disorder was 
associated with older age (U = 33355, Z = -2.104, p = 0.035), while the prevalence of 
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12-month use of psychoactive substance was significantly associated with charges of 
violent offences (χ2=13.55, p˂0.01).
Conclusively, there is a high prevalence of psychoactive substance use and disorders 
among new prison inmates with tobacco, cannabis and alcohol as the commonest. Giv-
en that male gender, unemployment, parental divorce and parental drug use increase 
the likelihood of these disorders, it will be worthwhile for any drug intervention program 
to address these factors.
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INTRODUCTION
Data from the United Nations Office 
on Drugs and Crime (UNODC) suggest 
that the annual global prevalence of any 
psychoactive substance use in 2016 was 
5.6% (UNODC, World Drug Report 2018). 
The situation appears more alarming 
in Nigeria as a higher number of people 
have recently been reported to be using 
psychoactive substances. This observa-
tion was made in the 2018 National Drug 
Use Survey in Nigeria, where the annual 
prevalence of any psychoactive substance 
use in 2017 was 14.4% (UNODC, Drug Use 
in Nigeria 2018).
The global pattern of psychoactive 
substance use reported the most fre-
quently used substances to be cannabis, 
opioids and stimulants, whereas cocaine 
use was the least frequent (UNODC, 
World Drug Report 2018). While the 
National Drug Use Survey in Nigeria cor-
roborated the global pattern of use, a 
community-based study (Gureje et al, 
2007) earlier conducted in Nigeria re-
ported a different pattern of use, where 
alcohol and tobacco were the most fre-
quently used substances, while cocaine 
had the least frequency of use (Gureje 
et al, 2007). Cannabis use was the fourth 
most prevalent after the use of seda-
tives which was reported as the third 
most prevalent in this same community-
based study (Gureje et al, 2007). Further 
research evidence has supported this 
pattern of use in the Nigerian general 
population (Ani, 2014; Babalola et al., 
2014; Omoluabi, 1995).
Several prison-based studies, both 
globally (Bronson et al, 2017; Esmaili, 
2016; Khalooei et al, 2016; Long et al., 
2004; Stover & Michels, 2010; Vicens 
et al, 2011) and in Nigeria (Ogunwale et 
al, 2012), have reported the prevalence 
of psychoactive substance use between 
66.7% and 77%, which is comparatively 
higher than the general population find-
ings that ranged between 3.4% and 14.4% 
(Steel et al, 2014; UNODC, Drug Use in Ni-
geria 2018).
Some of these psychoactive substance 
users experience disorders such as abuse 
and dependence (Fazel et al., 2017). In 
one prison-based study in Ireland, 58% 
of the participants had substance depen-
dence (Mohan et al, 2006); whereas in In-
dia, 47.1% of the prison inmates had sub-
stance use disorder (Ayirolimeethal et al, 
2014). More so, about one quarter of the 
prison inmates that participated in a pris-
on-based study in the United States had 
substance use disorder (James & Glaze, 
2006). In Nigeria, 20.1-54% of prison 
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inmates have been reported to have 
suffered from these disorders (Abdulma-
lik et al, 2014; Armiya’u et al, 2017). 
A prison is a stressful environment as-
sociated with regimented life style, over-
crowding, social deprivation, and bullying 
from other inmates (Mansoor et al, 2015; 
Sykes, 1958). More so, it is a high-risk en-
vironment for initiation (Boys et al., 2002) 
and continuation of drug use (Rowell et 
al., 2012; Rowell-Cunsolo et al., 2016). 
While some offenders with psychoactive 
substance use were remanded in prison 
due to drug use (Clarke et al., 2001; Row-
ell et al., 2012), others got remanded on 
account of offences not related to drugs. 
In either case, they may continue to use 
psychoactive substance (Clarke et al., 
2001; Cope, 2003; Rowell et al., 2012; 
Rowell-Cunsolo et al., 2016) as a coping 
strategy despite prohibition by the insti-
tution (Caulkins & Sevigny, 2005; Skow-
ronski & Talik, 2018).
Some demographic and family factors 
such as age, adverse childhood experi-
ences, polygamous family setting, and 
parental deprivation following parental 
separation or divorce have been found 
to increase the likelihood of psychoac-
tive substance use and other behavioural 
problems (Akanni & Adayonfo, 2015; Al-
Sharfi et al, 2016; Fatoye, 2003; Jogdand 
& Naik, 2014; McGee et al., 2011). 
Adverse childhood experiences which 
include childhood maltreatment, paren-
tal separation or divorce, parental drug 
use, and exposure to domestic violence 
in the family are important aspects of life 
that largely affect the process of human 
development, and which may further 
lead to psychoactive substance use and 
other health risk behaviors (Francisco et 
al., 2013; Bellis et al., 2014; Hughes et al., 
2017).
Gender influence on psychoactive sub-
stance use in the prison population has 
been inconsistent. While some authors 
found the use of psychoactive substance 
to be higher among female prison inmates 
than among the male inmates (Bronson 
et al, 2017; Fazel et al, 2017); others have 
reported a higher prevalence among male 
inmates (Mendes dos Santos, 2014; Row-
ell-Cunsolo et al, 2016).
Similarly, a higher prevalence of psy-
choactive substance use has been asso-
ciated with social disadvantages such as 
unemployment, poverty, and low level of 
education (Rowell-Cunsolo et al, 2016). 
The majority of the prison inmates pri-
or to their imprisonments experienced 
these social disadvantages which, in the 
presence of the stressful prison environ-
ment, may account for the overrepresen-
tation of psychoactive substance users 
in the prison (Mendes dos Santos, 2014; 
Fazel et al., 2017; Lukasiewicz, 2007; Row-
ell-Cunsolo et al, 2016). 
This study was relevant following the 
dearth of studies on associated factors 
of drug use among new prison inmates 
especially in Sub-Saharan Africa; the 
benefit of early recognition of these 
problems and concerted effort toward 
intervention and policy making in custo-
dial centers; the barriers posed by these 
problems to any meaningful rehabilita-
tion and intervention in a correctional 
facility (Baltieri, 2014); and the need to 
address the gap in literature. Hence, our 
study was guided by the following objec-
tives (1) to determine the prevalence of 
psychoactive substance use and disorder 
(2) to assess the pattern of use and dis-
order (3) to address its association with 
type of offence (4) and to evaluate its re-
lationship with family and socio-demo-
graphic factors. 
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METHOD
Study design and setting 
This was a cross-sectional study con-
ducted in Enugu Maximum Security Cus-
todial Center (formerly known as the 
Enugu Maximum Security Prison); and 
which was established in 1915 with a 
statutory capacity of 638 (Okoro et al., 
2018). However, there were between 
1901 and 2097 prison inmates in its 
custody during the time of the study. 
It accommodates all classes of prison 
inmates including those on death row, 
life sentences, awaiting-trial prison in-
mates, short and long term sentences. It 
also accommodates both the male and 
female inmates, but in different wings 
(Okoro et al., 2018). There are differ-
ent cells for the different classes of in-
mates; and in addition, all new inmates 
are first kept in a different cell until they 
appear before the prison admission 
board. Thereafter, they are assigned to 
their respective cells according to their 
offences.
Participants and sample size calculation
The sample size for the study was cal-
culated using the formula: n=Z2P (1-P)/d2 
(Araoye, 2003). 
Where: n = Sample Size. P = the pro-
portion of the target population with the 
problem.
Z = the Standard normal deviate, set at 
1.96 which corresponds to the 95% confi-
dence level.
d = precision, tolerable margin of error 
set at 5% (0.05).
To calculate ‘n,’ we used the value of 
‘p’ in the study done by Armiya’u et al., 
(2017) in a Maximum Security Prison in 
Jos, Nigeria. They found substance use 
disorder in 54% of the participants. Thus, 
sample size ‘n’ was calculated as: n = 
(1.96)2(0.54)(1 - 0.54)/(0.05)2 = 382
Though 382 was the estimated mini-
mum sample size. However, this was a 
part of a larger study design that followed 
the participants up for 6 months, and in 
which dropout rate was expected to be 
high as a result of inmates being released 
from the prison, we used a sample size of 
552 which makes allowance for 30% attri-
tion at the 6th month. 
A total of 552 inmates were recruited 
by a convenient sampling between 3rd of 
May and 4th October, 2019, and this rep-
resented 95.5% of the total 578 inmates 
(25 females versus 553 males, 546 await-
ing-trial inmates versus 32 sentenced in-
mates) remanded in custody during this 
period. Twenty six inmates (4.5%) did not 
participate in the study, out of which 19 
(3.3%) were already discharged from pris-
on custody before the day of interview for 
several reasons including the completion 
of their prison sentences, and the fulfill-
ment of their bail conditions; while the 
remaining 7 (1.2%) declined to give con-
sent after the purpose of the interview 
was explained to them. 
Data collection procedure
The study lasted between 3rd May and 
4th October, 2019, and all new inmates 
brought to prison custody within this pe-
riod appeared before the prison admis-
sion board within their first 24-72 hours 
of imprisonment. The interview which 
was done twice a week occurred within 
their first week of imprisonment after 
they had gone through the prison admis-
sion process. On each interview day a list 
of all new prison inmates that attended 
the preceding prison admission process 
was obtained from the prison record, 
and with the assistance of a staff of the 
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custodial center, they were all brought to 
the medical unit of the center, where the 
interview was done. The aim of the study 
was explained to these new inmates that 
were usually between 10 and 15 for ev-
ery interview day; thereafter, consent was 
obtained from them, and those who con-
sented were selected for the study.
The interview was done in 2 stages; the 
first was the administration of the socio-
demographic questionnaire designed by 
the researchers to all the selected par-
ticipants. Those that could read and write 
had the questionnaire self-administered, 
while those that could not read or write 
were assisted by the researchers who 
read the questions out to them and guid-
ed them in ticking their responses. 
Those that responded “yes” to the 
item on the socio-demographic ques-
tionnaire that enquired if they had ever 
used any psychoactive substance pro-
ceeded to the second stage which was 
the administration of the substance and 
alcohol modules of the MINI-Plus to 
them by two of the researchers who are 
psychiatrists.
The interviews with the MINI-Plus com-
menced when the 5th co-author who is a 
specialist psychiatrist had achieved sat-
isfactory inter-rater reliability with the 
corresponding author, a consultant psy-
chiatrist with experience in the use of the 
MINI-Plus. Thereafter, they conducted 
each interview simultaneously, in which 
one interviewer carried out the inter-
view and the other was an observer who 
nevertheless, asked necessary questions 
during the interview for further clarifica-
tion. Each participant was independently 
scored by the two interviewers. The colla-
tion of the results of the two interviewers 
was done in such a way that any agree-
ment in the two interviews was recorded 
as a case (having the diagnosis), while 
where there was no agreement between 
the two interviewers, the participant was 
recorded as having no case (not having 
the diagnosis). The average time spent on 
the two stages of the interview on each 
participant was 20 minutes. 
Inclusion criteria
All the new inmates that had not spent 
more than 1 week and had gone through 
the prison admission board were includ-
ed in the study.
All inmates who gave written informed 
consent were selected for the study.
Exclusion criterion:
All new inmates who were transferred 
from other custodial centers to the study 
center during the period of the study 
were excluded.
Ethics
Permission for the study was sought 
and obtained from the authority of the 
Nigerian Correctional Service, Enugu 
State Command, and ethical approval 
was obtained from the State Ministry of 
Health, Enugu State, Nigeria. The objec-
tives of the study were explained to the 
participants and they were assured of 
confidentiality of their information. They 
were made to understand that participa-
tion in the study was voluntary and that 
they could withdraw at any point even 
after they had given their consent and 
that such withdrawal wouldn’t affect 
them negatively. Thereafter, both verbal 
and written consent were obtained from 
them. Furthermore, with the consent of 
those with drug use problems and in need 
of therapy, they were referred to the 
prison authority, with the hope of good 
health care services for them.
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Instruments
Socio-Demographic Questionnaire:
A socio-demographic questionnaire de-
signed by the researcher was used to elic-
it socio-demographic and forensic infor-
mation from each consenting participant. 
The information elicited were age, sex, re-
ligion, marital status (never married, mar-
ried, or separated/divorced/widowed), 
level of education (no formal education, 
primary school, secondary school, or ter-
tiary education), and ethnicity (Hausa, 
Igbo, Yoruba, Other ethnicity in Nigeria, 
or countries other than Nigeria). Others 
were prison category (awaiting-trial ver-
sus sentenced), type of offence (violent 
versus non-violent), and family setting 
(polygamous versus monogamous family 
setting). In the remaining questions, the 
participants had a “yes,” or “no” option to 
choose from. Sample items of such ques-
tions were: Did you live in the state capi-
tal before your imprisonment? Have you 
ever used any psychoactive substance 
(this includes the use of alcohol)? As a 
child (before you turned 18 years), did 
any of your parents use drug? As a child 
(before you turned 18 years), were your 
parents divorced or separated?
Mini International Neuropsychiatric 
Interview-Plus (MINI-Plus) English 
version 6.0.0
The Mini International Neuropsychi-
atric Interview – Plus (MINI – Plus) is a 
modified version of the original MINI 
which was designed as a brief structured 
interview for major axis 1 psychiatric dis-
orders in DSM-IV and ICD-10 (Sheehan et 
al., 1998). The MINI was developed jointly 
by psychiatrists and clinicians in the Unit-
ed States and Europe, and designed for 
epidemiological studies and multicentre 
clinical trials. Validation and reliability 
studies have been done comparing the 
MINI to the Structured Clinical Interview 
for DSM-III-R (SCID) and the Composite 
International Diagnostic Interview (CIDI)- 
a structured interview developed by the 
World Health Organization for lay inter-
viewers for International Classification of 
Diseases, ICD-10 (Sheehan et al., 1998). 
The results of these studies showed 
that the MINI has high validity and re-
liability, and can be administered in a 
much shorter period of time (usually an 
average of 15 minutes) than the SCID and 
CIDI (Sheehan et al., 1998). It has a sat-
isfactory psychometric property including 
a good inter-rater reliability of 0.67-0.85 
and a satisfactory concordance (Kappa 
value greater than 0.88) between it and 
expert diagnoses (Mukhtar et al., 2012).
Each module of the MINI (e.g., the psy-
choactive substance use module) has two 
parts. The first is a screener, consisting of 
two or three main symptoms to assess the 
probability of the presence of the disor-
der; while the second is the diagnostic part 
which is applied if the subject tests posi-
tive to the screener (Sheehan et al., 1998).
The MINI-plus has additional modules 
for somatization disorders, lifetime alco-
hol dependence, lifetime alcohol abuse, 
lifetime substance (non-alcohol) depen-
dence, and lifetime substance (non-alco-
hol) abuse (Black et al., 2004).
The MINI – Plus has been used in Nige-
ria to conduct a study in the prison popu-
lation (Abdulmalik et al., 2014), and our 
study utilized it to make diagnoses of psy-
choactive substance use disorders among 
the participants.
Data analysis
The data collected were entered into 
the Statistical Packages for Social Sciences, 
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version 20 (IBM-SPSS). A frequency check 
was run on the data to check for missing 
data. A test of normality done using the 
Kolmogorov–Smirnov test showed that 
age distribution was not normally distrib-
uted (p˂0.05). A Mann Whitney U test was 
used to assess the relationship between 
age and psychoactive substance use/dis-
order, while a Chi-squared test was used 
to demonstrate the association between 
psychoactive substance use/disorder and 
all independent categorical variables. Bi-
nary regression was further applied for 
all socio-demographic variables that had 
significant association with psychoactive 
substance disorder on univariate analysis. 
All tests of significance were two-tailed 
at the 5% level of significance and confi-
dence interval estimation of 95%.
Results
Table 1: The mean age of the partici-
pants was 28.09±8.92, with 528 (95.7%) 
of them being males and 24 (4.3%) be-
ing females. Three hundred and sixty 
eight (66.7%) were unemployed, while 
184 (33.3%) were employed; 206 (37.3%) 
never had secondary education, and the 
remaining 346(62.7%) had at least sec-
ondary education.
The 12-month prevalence of any psy-
choactive substance disorder was signifi-
cantly higher among the male inmates 
(52.3%) than the female inmates (16.7%). 
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Table 1. Association between socio-demographic factors and psychoactive substance 
disorder.
Variables 
Lifetime prevalence of any 
substance disorder
χ2
P 
value
12-month prevalence of any 
substance disorder
χ2
P 
value
Absent
Freq (%) 
Present
Freq (%)
Absent 
Freq (%)
Present
Freq(%)
Gender
Female
Male 
19(79.2)
216(40.9)
5(20.8)
312(59.1)
13.74 ˂0.01*
20(83.3)
252(47.7)
4(16.7)
276(52.3)
11.6 0.01*
Settlement
Rural
Urban 
100(46.7)
135(39.9)
114(53.3)
203(60.1)
2.47 0.12
110(51.4)
162(47.9)
104(48.6)
176(52.1)
0.63 0.43
Marital status
Never married
Married
Sep/div/widow
139(44.1)
78(41.9)
18(35.3)
176(55.9)
108(58.1)
33(64.7)
1.45 0.49
154(48.9)
94(50.5)
24(47.1)
161(51.1)
92(49.5)
27(52.9)
0.24 0.89
Job status
Unemployed
Employed
145(39.4)
90(48.9)
223(60.6)
94(51.1)
4.54 0.03*
166(45.1)
106(57.6)
202(54.9)
78(42.4)
7.67 0.01*
Education
None/Primary
Sec/tertiary
81(39.3)
154(44.5)
125(60.7)
192(55.5)
1.42 0.23
94(45.6)
178(51.4)
112(54.4)
168(48.6)
1.75 0.19
Mean Rank U Mean Rank U
Age(mean=28)
No
Yes 
235
317
259.9
288.8
33355 0.035*
272
280
275.66
277.31
37853 0.90
*=Significant value. Sep=separated. Div=Divorced. Freq=Frequency. %=Percent. 
χ2=Chi-squared test. U=Mann-Whitney test. Sec=Secondary education.
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Similarly, lifetime prevalence of any psy-
choactive disorder was significantly 
higher among male (59.1%) than female 
(20.8%) inmates (p˂0.05). The partici-
pants who lived in the urban areas had 
higher lifetime (60.1%) and 12-month 
(52.1%) prevalence of any psychoactive 
substance disorder than the rural settlers 
that had 53.3%, and 48.6%, respectively.
The prison inmates that were unem-
ployed were significantly more likely 
than the employed ones to have lifetime 
(60.6% versus 51.1%); and 12-month 
(54.9% versus 42.4%) prevalence of any 
psychoactive substance disorder. One 
hundred and sixty eight (48.6%) of the 
346 inmates that attended at least sec-
ondary school had 12-month prevalence 
of psychoactive substance disorder, while 
112 (54.4%) of the 206 that did not attend 
secondary school had the disorder.
Lifetime disorder was seen in 192 
(55.5%) of the 346 that attended at least 
secondary school, whereas 125 (60.7%) 
of the 206 that did not attend secondary 
school had the disorder. A Mann-Whitney 
U test was done to determine if there 
were differences in age between those 
with lifetime psychoactive substance dis-
order and those without. The difference 
in age for those with lifetime disorder 
(mean rank = 288.8) and those without 
(mean rank = 259.9) were statistically sig-
nificant (U = 33355, Z = -2.104, p = 0.035).
Table 2 is the prevalence and pattern 
of psychoactive substance use, and it 
shows that 478 (86.6%) of the partici-
pants have used any psychoactive sub-
OKORO ET AL 
Table 2. Prevalence and pattern of psychoactive substance among the participants
 N=552
Prevalence of psychoactive substance disorder
Lifetime 
Frequency(percent)
Annual
Frequency(percent) 
Ever used any psychoactive substance
Non-alcohol psychoactive substance use
478(86.6)
287(52.0)
405(73.4)
255(46.2)
Any psychoactive substance disorder
Substance (excluding alcohol) disorder
Tobacco disorder
Cannabis disorder
Alcohol disorder
Opioid disorder
Cocaine disorder
Tranquilizer disorder
317(57.4)
276(50.0)
266(48.2)
203(36.8)
40(7.2)
23(4.2)
12(2.2)
5(0.9)
280(50.7)
243(44.0)
227(41.1)
179(32.4)
38(6.9)
15(2.7)
7(1.3)
4(0.7)
Any drug abuse
Tobacco abuse
Cannabis abuse
Alcohol abuse
Opioid abuse
Cocaine abuse
71(12.9)
37(6.7)
50(9.1)
7(1.3)
2(0.4)
2(0.4)
66(12.0)
32(5.8)
47(8.5)
5(0.9)
1(0.2)
1(0.2)
Any drug dependent
Tobacco dependent
Cannabis dependent
Alcohol dependent
Opioid dependent
Cocaine dependent
Tranquilizer dependent
276(50.0)
229(41.5)
153(27.7)
33(6.0)
21(3.8)
10(1.8)
4(0.7)
241(43.7)
195(35.3)
132(23.9)
33(6.0)
14(2.5)
6(1.1)
4(0.7)
Multiple psychoactive substance disorder 180(32.6) 156(28.3)
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stance in their lifetime, while 405 (73.4%) 
used it in the last 12 months. The lifetime 
and 12-month prevalence of any psycho-
active substance disorder were 57.4%, 
and 50.7%, respectively. Tobacco dis-
order had the highest lifetime (48.2%) 
and 12-month (41.1%) prevalence. The 
second most prevalent was cannabis 
lifetime (36.8%) and 12-month (32.4%) 
disorders. This was followed by alcohol 
lifetime (7.2%) and 12-month (6.9%) dis-
order. The lifetime prevalence of opioid 
disorder was 4.2%, while its 12-month 
prevalence was 2.7%. 
Table 3 shows the association between 
family factors and the prevalence of psy-
choactive substance disorders. Though 
not statistically significant, the prison 
inmates from a polygamous family set-
ting were more likely than those from a 
monogamous family setting to have life-
time (61.5% versus 55.3%) and 12-month 
prevalence (52.6% versus 49.7%) of any 
psychoactive substance disorder.
Comparing those whose parents were 
divorced to those whose parents were not 
divorced, there was significant higher life-
time (82.7% versus 54.8%) and 12-month 
(75.0% versus 48.2%) prevalence of any 
psychoactive substance disorder (p<0.01).
Those that their parents used drugs 
were significantly more likely than those 
whose parents did not use drugs to have 
higher lifetime (68.2% versus 50.4%) and 
12-month (59.9% versus 44.8%) disorders 
(p<0.05).
Table 4 shows the association between 
psychoactive substance use history and 
socio-demographic factors. More men 
(87.9%) than women (58.3%) have used 
any psychoactive substance in their life-
time; and this was statistically significant. 
The 12 month prevalence of the use of 
any psychoactive substance was also 
found to be significantly higher among 
the male (74.8%) than the female (41.7%) 
inmates (p<0.05). 
The inmates that were widowed/sepa-
rated/divorced (78.4%) had the highest 
12 month prevalence of any psychoactive 
substance use compared to those who 
were never married (74.3%) and those 
who were married and still living with 
their spouse (70.4%).
While the 12 month rate of any psycho-
active substance use was higher among 
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Table 3. Association between family factors and psychoactive substance history
Family factors
Lifetime prevalence of any 
substance disorder
χ2
P 
value
Annual prevalence of any 
substance disorder
χ2
P 
value
Absent
Freq(%) 
Present
Freq(%)
Absent 
Freq(%)
Present 
Freq(%)
Family setting
Monog (n=360) 
Polyg (n=192)
161(44.7)
74(38.5)
199(55.3)
118(61.5)
1.96 0.16
181(50.3)
91(47.4)
179(49.7)
101(52.6)
0.42 0.52
Parental Div
No (n=500)
Yes (n=52) 
226(45.2)
9(17.3)
274(54.8)
43(82.7)
14.99 ˂0.01*
259(51.8)
13(25.0)
241(48.2)
39(75.0)
13.54 ˂0.01*
Parental drug
No (n=335)
Yes (n=217) 
166(49.6)
69(31.8)
169(50.4)
148(68.2)
16.98 ˂0.01*
185(55.2)
87(40.1)
150(44.8)
130(59.9)
12.06 0.01*
Monog=Monogamy. Polyg=Polygamy. Div=Divorce. Freq=Frequency. χ2=Chi-squared test
*=significant value.
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those that were unemployed (75.8) than 
those who were employed prior to in-
carceration (68.5%); the lifetime use was 
higher among the employed (87.5%) than 
the unemployed (86.1%).
Those that attended at least secondary 
school (88.2%) were more likely to have 
used any substance in their lifetime when 
compared to those that did not attend 
secondary school (84.0%). Those with 
lifetime use were significantly more like-
ly to be older (mean rank = 287.7) than 
those without (mean rank = 204.5). U = 
12355, Z = -4.18, p˂0.001. Furthermore, 
of the 267 participants charged with vio-
lent offences, 215 (80.5%) of them had 
used psychoactive substance in the last 
12 months prior to incarceration, while 
190 (66.7%) of the 285 charged with non-
violent offences had used psychoactive 
substance in the past 12 months. Lifetime 
psychoactive substance use was among 
243 (91%) of those charged with violent 
offences, and among 235 (82.5%) of those 
charged with non-violent offences. These 
differences were statistically significant 
(p<0.01).
Table 5 shows that all the variables 
that were significantly associated with 
12-month prevalence of psychoactive 
substance disorder on univariate analy-
sis were also predictive of the presence 
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Table 4. Association between psychoactive substance use history and socio-
demographic factors.
Variables 
Lifetime use of any 
substance
χ2
P 
value
Annual prevalence of any 
substance use 
χ2
P 
value
Absent
Freq(% 
Present
Freq(%)
Absent
Freq(%)
Present 
Freq(%)
Gender
Female 
Male
10(41.7)
64(12.1)
14(58.3)
464(87.9)
17.3 ˂0.01*
14(58.3)
133(25.2)
10(41.7)
395(74.8)
12.9 ˂0.01*
Settlement
Rural
Urban 
26(12.1)
48(14.2)
188(87.9)
290(85.8)
0.48 0.49
54(25.2)
93(27.5)
160(74.8)
245(72.5)
0.35 0.56
Marital status
Never married
Married
Sep/div/widow
47(14.9)
23(12.4)
4(7.8)
268(85.1)
163(87.6)
47(92.2)
1.94 0.34
81(25.7)
55(29.6)
11(21.6)
234(74.3)
131(70.4)
40(78.4)
1.63 0.44
Job status
Unemployed
Employed
51(13.9)
23(12.5)
317(86.1)
161(87.5)
0.20 0.66
89(24.2)
58(31.5)
279(75.8)
126(68.5)
3.38 0.07
Education
None/pry
Sec and above
33(16.0)
41(11.8)
173(84.0)
305(88.2)
1.93 0.16
61(29.6)
86(24.9)
145(70.4)
260(75.1)
1.50 0.22
Type of offence
Non-violent
Violent
50(17.5)
24(9.0)
235(82.5)
243(91.0)
8.69 ˂0.01
95(33.3)
52(19.5)
190(66.7)
215(80.5)
13.55 ˂0.01
Mean Rank U Mean Rank U
Age
No
Yes 
74
478
204.5
287.7
12355 ˂0.01
147
405
283.1
274.1
28800 0.56
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of psychoactive substance disorder 12 
months prior to incarceration on further 
analysis using the logistic regression. Un-
employment with an OR of 1.8(95% C.I: 
1.24 – 2.60) puts the inmates at greater 
odds of having psychoactive substance 
disorder 12 months prior to incarcera-
tion. More so, the odds of this disorder in 
the 12 months preceding incarceration is 
less likely among female inmates (β=0.12, 
95% [CI: 0.04, 0.39]); inmates without his-
tory of parental divorce (β=0.29, 95% (CI: 
0.14, 0.59]); and those without history of 
parental drug use (β=0.56, 95% (CI: 0.39, 
0.81]).
It also shows that, while unemploy-
ment with an OR of 1.6(95% C.I: 1.10 – 
2.33) puts the inmates at greater odds of 
having psychoactive substance disorder 
in their lifetime, the odds of the preva-
lence of lifetime psychoactive substance 
disorder was less likely among female in-
mates (β=0.12, 95% [CI: 0.04, 0.35]); in-
mates without history of parental divorce 
(β=0.23, 95% [CI: 0.10, 0.52]); and those 
without history of parental drug use 
(β=0.5, 95% [CI: 0.34, 0.72]).
DISCUSSION
Our study explored the prevalence and 
pattern of psychoactive substance disor-
ders or use, and the extent to which these 
are associated with socio-demographic 
characteristics, the type of offence, and 
family dysfunction and setting. 
Globally (Bronson et al., 2017; Rowell-
Cunsolo et al., 2016; Sahajian et al., 2006) 
and in Nigeria (Armiya’u et al., 2017), 
evidence from research has shown a high 
prevalence of psychoactive substance use 
and disorder in the prison population. 
Our result of a high rate of psychoactive 
substance use is consistent with these 
findings. While it was observed that our 
participants had stayed about 4 days in 
prison custody and as such our result may 
be likened to that of the general popula-
tion, it is also noteworthy to emphasize 
the large difference between our rate 
and the rate of Nigeria’s national survey. 
For example, our finding of 73.4% an-
nual prevalence of any psychoactive sub-
stance use far exceeds the 14.4% annual 
prevalence of the 2017 national survey 
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Table 5. Predictors of drug disorder using logistic regression
12 months prevalence of PS disorder B S.E Wald df Sig Exp(B)
95% C.I Exp(B)
Lower Higher 
Intercept 1.199 0.373 10.321 1 0.001 3.317
Gender -2.097 0.591 12.573 1 ˂0.001* 0.123 0.039 0.391
Job status 0.584 0.190 9.471 1 0.002* 1.794 1.236 2.602
Parental divorce -1.240 0.360 11.851 1 0.001* 0.289 0.143 0.586
Parental drug -0.572 0.185 9.581 1 0.002* 0.564 0.393 0.811
Lifetime prevalence of PS disorder
Intercept 1.866 0.429 18.922 1 ˂0.001* 6.462
Gender -2.157 0.561 14.786 1 ˂0.001* 0.116 0.039 0.347
Job status 0.470 0.191 6.047 1 0.014* 1.599 1.100 2.325
Parental divorce -1.464 0.414 12.518 1 <0.001* 0.231 0.103 0.520
Parental drug -0.704 0.190 13.693 1 ˂0.001* 0.495 0.341 0.718
*=Significant value. df = Degree of freedom. C.I=Confidence interval. PS=psychoactive substance.
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in Nigeria (UNODC, Drug Use in Nigeria 
2018). This implies that psychoactive sub-
stance use is increasing and this poses a 
serious challenge not only to the prison 
authority, but also to the other compo-
nents of the justice system (the judiciary 
and the police), as well as to the society 
at large.
Specifically, the pattern of psychoactive 
substance use among new prison inmates 
(Sahajian et al.,2006), other prison in-
mates (Armiya’u & Perez, 2016; Ugwuoke 
& Ifeanyichukwu, 2016), and the general 
population in Nigeria (Ani, 2014; Babalola 
et al., 2014; Gureje et al., 2007) found to-
bacco, cannabis, and alcohol as the most 
commonly used drugs. Our study repli-
cates this pattern, and this reflects the 
ease of access of these psychoactive sub-
stances. The vital social roles and accep-
tance of alcohol, the few laws in Nigeria 
governing the use and restriction of alco-
hol and cigarette, and the low cost of ciga-
rette and cannabis further explain the high 
prevalence of these specific substances. 
Previous studies found that males 
were more likely than females to report 
psychoactive substance use and disor-
der (Tsekane & Amone-P’Olak, 2019; Ug-
wuoke & Ifeanyichukwu, 2016). In one 
study to determine the factors contribut-
ing to psychoactive substance use among 
medical students in Nigeria, men were 
found to be more likely than women to 
have psychoactive substance use (Baba-
lola et al., 2014). Other studies (Becker 
& Hu, 2008; Eggen, 1994) echoed similar 
report of a higher prevalence of disorder 
among men compared to women. Our 
finding in which males were three times 
as likely as females to have psychoactive 
substance disorders lend more support to 
the literature findings. This was unsurpris-
ing given that the society frowns at the 
use of drugs such as alcohol and cigarette 
by a female, while it accommodates such 
act by a male; and that more males than 
females have access and opportunity to 
drug availability.
Previously, it has been established that 
increasing age (Eggen, 1994) and unem-
ployment (Lee et al., 2015) were associ-
ated with psychoactive substance disor-
der. Our result corroborates the findings 
of a previous study in which unemploy-
ment was a predictor of drug use (Henkel, 
2011), and also agrees with the report 
of another study in which there was a 
positive correlation between psychoac-
tive substance use and age (Ugwuoke & 
Ifeanyichukwu, 2016). Given the youthful 
age of our participants, the explanation 
for our result may not be unconnected to 
the fact that drug use increases with age 
at initial stage, then peaks at early adult-
hood before declining. A possible reason 
for high drug prevalence among the un-
employed in our study can be attributed 
to the fact that employed individuals are 
more likely to be occupied with their jobs 
and as such, dedicate little or no time to 
drug use; the reverse could be inferred 
for those unemployed. Our study further 
contributes to the stress hypothesis of 
unemployment as a cause of drug use in 
which unemployment, through worsen-
ing of stress, predisposes an individual to 
the use of drug as a way of coping with 
the stress (Nagelhout et al., 2017; Wills, 
1986; Wills & Hirky, 1996).
This implies that while the design of 
a drug treatment program in the prison 
should focus more on the youth, all prison 
inmates especially those with a history of 
drug use, should be equipped with voca-
tional skills so that upon discharge from 
prison custody they can be meaningfully 
engaged. 
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Previous research findings (Armiya’u et 
al., 2017; Armiya’u & Adole, 2015) have 
also associated psychoactive substance 
use and violent offence. This was con-
firmed in our study in which the use of 
psychoactive substance was commoner 
among those charged with violent offenc-
es. This finding is not unexpected given 
that substance abuse can impair cogni-
tive, social and psychological functions 
such that emotional and intellectual abili-
ties are compromised (Jiloha, 2009). In 
the presence of this impairment, there is 
also impaired ability to assess risk, which 
further increases impulsivity, with vio-
lence as its resultant effect (Armiya’u et 
al., 2017).
More so, the complications of psycho-
active substance use such as craving, in-
toxication, and psychosis, may drive an 
individual to violence and other crimi-
nal behaviors as was reported in the U.S 
study in which 30% of drug users were 
found to have committed violent crimes 
under the influence of alcohol (Daderman 
et al, 2002).
Finally, we observed that psychoactive 
substance disorder was predicted by ex-
posure to parental drug use and divorce. 
This is in tandem with several reports in 
the literature (Akanni & Adayonfo, 2015; 
Anderson, 2014; Hemovich & Crano, 
2009; Lander et al., 2013). The interac-
tion between risk (parental divorce and 
parental drug use) and protective (pa-
rental affection, monitoring, and reward) 
factors in the family are pivotal in predict-
ing psychoactive substance use in adult 
life (Muchiri & dos Santos). Therefore, 
if this interplay between protective and 
risk family factors is understood, inter-
ventions should be tailored to address it. 
Thus, policies and awareness programs 
aimed at preventing or reducing drug use 
should consider the promotion of positive 
child rearing practices, friendly family en-
vironment, and other protective factors in 
the family. 
Our study which has the potential to 
contribute to the body of knowledge in 
forensic psychiatry is not without limi-
tations. Therefore, the interpretation of 
our results should be guided by the fol-
lowing limitations. First, reports from our 
participants on family dysfunctions may 
raise concern about response bias as they 
may not want to present themselves in 
negative light before the correctional of-
ficers. Second, participants for the study 
were recruited from just one prison in 
Nigeria; therefore, the results cannot be 
generalized as representative of all new 
prison inmates in Nigeria. Third, caution 
should be applied while interpreting the 
relationship between gender and psycho-
active substance use since the number of 
males outnumbers that of the females. 
Finally, the retrospective nature of the 
responses to questions that assessed 
family dysfunction raises concern about 
recall bias. 
CONCLUSION
This study has shown a high rate of 
psychoactive substance use among newly 
admitted prison inmates; with the pat-
tern showing that tobacco is the most 
used followed by cannabis and alcohol. 
This study has also elaborated the socio-
demographic distribution of psychoactive 
substance among the study population. 
This information will help prison admin-
istrators and policy makers to incorporate 
and institute psychoactive substance use 
assessment as well as treatment pro-
grams for newly admitted prisoners.
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RECOMMENDATION
Authors recommend that for efficient 
rehabilitation and reformation of prison 
inmates, screening of new inmates for 
history of drug use or disorder should 
be routinely done. Also, inmates should 
be equipped with vocational skills as this 
will keep them engaged after they are 
released from prison; thus, preventing 
recidivism, relapse of drug use/disorder, 
and violent offences.
Finally, future studies should consider 
a national survey in which the data ob-
tained can be a representation of the na-
tion’s drug use history among new prison 
inmates.
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